# Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A

> **NCT06658002** · PHASE3 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 150 (estimated)

## Conditions studied

- Fungal Keratitis
- Corneal Ulcer

## Interventions

- **DRUG:** Cyclosporine A
- **OTHER:** Placebo Comparator: Placebo

## Key facts

- **NCT ID:** NCT06658002
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-09-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-10-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06658002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06658002, "Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06658002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*